NCT04248998 2023-01-18
BREAKFAST
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
Clinical Trials
4 trialsNCT04243434 2020-04-16
PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients
Acrotech Biopharma Inc.
Phase 1 Unknown
NCT01917578 2013-08-06
BCSMANC
Shandong Cancer Hospital and Institute
Phase 3 Unknown
NCT01415336 2011-08-11
AX Versus AC as Adjuvant Treatment for Node-Negative Breast Cancer
Peking Union Medical College Hospital
Phase 2/3 Unknown